BioSpace News Archive

Olon S.p.A. announced today the acquisition of Capua BioServices S.p.A., a global provider of CDMO services in the field of microbial fermentation, as part of a continuing expansion of its global footprint.

First Quarter Results Exceed Guidance

Company’s Open Eyes charity fund creates comfortable space for children to spend free time during treatment

Acerus Pharmaceuticals Corporation is today advising that it has received a Notice of Deficiency-Withdrawal Letter (“Notice”) for its GynoflorTM New Drug Submission.

The global PD-1 and PD-L1 Inhibitors market is expected to post a CAGR of over 19% during the period 2019-2023, according to the latest market research report by Technavio.

Cardax, Inc. (OTCQB: CDXI), a life sciences company focused on inflammatory health, today announced that its CEO, David G. Watumull, will present at NobleCon XV—Noble Capital Markets’ Fifteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida—on January 28th at 11:30 AM Eastern Standard Time.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year of 2018 on February 25, 2019 after the close of the financial markets.

H-PROOF and its mother/daughter founding duo Dr. Linda J. Kaplan, MD & Rachel S. Kaplan will be featured Friday, January 25th on the nationally syndicated daytime talk show, The Dr. Oz Show, the most powerful voice on television.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner Seelos Therapeutics, Inc. (NASDAQ: SEEL) announced that it has closed a reverse merger with Apricus Biosciences, Inc.

The Assistance Fund announced the launch of a new financial assistance program for individuals living with Lysosomal Acid Lipase Deficiency.